Data as of Jul 22
| -0.02 / -0.30%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 19.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +184.86% increase from the last price of 6.67.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.